Melanoma is predominantly a disease of older adults: the mean age at diagnosis is 65, and 65.7% of cases occur between ages 55 and 84. The classic ABCDE recognition rule is less reliable in this group, who more often present with nodular, amelanotic, or ulcerated tumors that do not meet the classic criteria, and patients 80 and older have far worse two-year survival once distant metastases are present (10.9% vs. 34.8% in patients under 40). Because no Medicare-covered standalone screening benefit exists, the primary care skin exam remains the default setting for early detection, making recognition and precise staging documentation among the highest-value clinical actions a care team can take.
AAVBC's Melanoma Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity by anatomic site, laterality, and metastatic spread, HCC/RAF V28 mapping across primary and metastatic disease categories, AJCC 8th-edition diagnostic staging thresholds, MEAT documentation standards, NCCN/ASCO-aligned treatment escalation by stage, medication safety for targeted and immune therapies, and referral and follow-up timing. Grounded in current NCCN and ASCO guidance, this guide supports consistent, individualized clinical decision-making, helping care teams recognize atypical presentations in older adults and document staging precisely, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of melanoma — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Melanoma is predominantly a disease of older adults: the mean age at diagnosis is 65, and 65.7% of cases occur between ages 55 and 84. The classic ABCDE recognition rule is less reliable in this group, who more often present with nodular, amelanotic, or ulcerated tumors that do not meet the classic criteria, and patients 80 and older have far worse two-year survival once distant metastases are present (10.9% vs. 34.8% in patients under 40). Because no Medicare-covered standalone screening benefit exists, the primary care skin exam remains the default setting for early detection, making recognition and precise staging documentation among the highest-value clinical actions a care team can take.
AAVBC's Melanoma Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity by anatomic site, laterality, and metastatic spread, HCC/RAF V28 mapping across primary and metastatic disease categories, AJCC 8th-edition diagnostic staging thresholds, MEAT documentation standards, NCCN/ASCO-aligned treatment escalation by stage, medication safety for targeted and immune therapies, and referral and follow-up timing. Grounded in current NCCN and ASCO guidance, this guide supports consistent, individualized clinical decision-making, helping care teams recognize atypical presentations in older adults and document staging precisely, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of melanoma — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
